CorMedix Inc. To Report First Quarter 2023 Financial Results and Provide a Corporate Update on May 15, 2023GlobeNewsWire • 05/08/23
CorMedix Inc. Announces Notice of Allowance for U.S. Patent Application Covering Lead Product DefenCathGlobeNewsWire • 05/01/23
Cormedix Inc. Announces Appointment of Robert A. Stewart to Its Board of DirectorsGlobeNewsWire • 04/17/23
How Much Upside is Left in CorMedix (CRMD)? Wall Street Analysts Think 198.21%Zacks Investment Research • 04/12/23
CorMedix Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 03/30/23
Cormedix Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results and Provide a Corporate Update on March 30, 2023GlobeNewsWire • 03/21/23
Cormedix Inc. Announces Presentation at Conference Showing Mortality Risk and Complications in Patients Experiencing Catheter Related Blood Stream InfectionsGlobeNewsWire • 12/06/22
CorMedix Inc. Reports Third Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 11/10/22
CorMedix Inc. to Report Third Quarter 2022 Financial Results and Provide a Corporate Update on November 10GlobeNewsWire • 11/02/22
CorMedix Inc. Announces Abstract Presentation at Upcoming American Society of Nephrology ConferenceGlobeNewsWire • 10/20/22
CorMedix Inc. (CRMD) CEO Joseph Todisco on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/11/22
CorMedix Inc. Reports Second Quarter and Six Month 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 08/11/22